- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.39 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 2 x MTE: PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER(Non-covalent)
MTE.3: 20 residues within 4Å:- Chain A: Q.113, C.151, G.805, A.806, F.807, G.808, R.921, M.1047, G.1048, Q.1049, G.1087, G.1088, S.1089, V.1090, V.1091, A.1092, Q.1203, L.1268, E.1270
- Ligands: MOS.5
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:Q.113, A:C.114, A:A.806, A:F.807, A:M.1047, A:Q.1049, A:V.1091, A:A.1092, A:Q.1203, A:Q.1203
MTE.8: 20 residues within 4Å:- Chain B: Q.113, C.151, G.805, A.806, F.807, G.808, R.921, M.1047, G.1048, Q.1049, G.1087, G.1088, S.1089, V.1090, V.1091, A.1092, Q.1203, L.1268, E.1270
- Ligands: MOS.10
10 PLIP interactions:10 interactions with chain B- Hydrogen bonds: B:Q.113, B:C.114, B:A.806, B:F.807, B:M.1047, B:Q.1049, B:V.1091, B:A.1092, B:Q.1203, B:Q.1203
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.4: 32 residues within 4Å:- Chain A: G.46, G.47, P.263, V.264, I.265, M.266, G.267, N.268, T.269, S.270, V.271, A.308, L.312, L.344, A.345, I.349, A.353, S.354, G.356, G.357, H.358, I.360, S.361, H.363, D.365, S.366, D.367, I.410, L.411, R.429, A.437, L.438
18 PLIP interactions:18 interactions with chain A- Hydrophobic interactions: A:A.345, A:I.349, A:I.349
- Hydrogen bonds: A:V.264, A:M.266, A:G.267, A:N.268, A:T.269, A:S.270, A:V.271, A:A.345, A:S.354, A:H.358, A:D.367, A:D.367, A:L.411, A:L.411, A:R.429
FAD.9: 32 residues within 4Å:- Chain B: G.46, G.47, P.263, V.264, I.265, M.266, G.267, N.268, T.269, S.270, V.271, A.308, L.312, L.344, A.345, I.349, A.353, S.354, G.356, G.357, H.358, I.360, S.361, H.363, D.365, S.366, D.367, I.410, L.411, R.429, A.437, L.438
19 PLIP interactions:19 interactions with chain B- Hydrophobic interactions: B:A.345, B:I.349, B:I.349
- Hydrogen bonds: B:V.264, B:M.266, B:G.267, B:N.268, B:T.269, B:T.269, B:S.270, B:V.271, B:A.345, B:S.354, B:H.358, B:D.367, B:D.367, B:L.411, B:L.411, B:R.429
- 2 x MOS: DIOXOTHIOMOLYBDENUM(VI) ION(Non-covalent)
MOS.5: 7 residues within 4Å:- Chain A: Q.776, A.919, F.923, G.1087, G.1088, E.1270
- Ligands: MTE.3
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.776, A:G.1088
MOS.10: 7 residues within 4Å:- Chain B: Q.776, A.919, F.923, G.1087, G.1088, E.1270
- Ligands: MTE.8
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Q.776, B:G.1088
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Foti, A. et al., Optimization of the Expression of Human Aldehyde Oxidase for Investigations of Single-Nucleotide Polymorphisms. Drug Metab.Dispos. (2016)
- Release Date
- 2016-02-17
- Peptides
- Aldehyde oxidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.39 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 2 x MTE: PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x MOS: DIOXOTHIOMOLYBDENUM(VI) ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Foti, A. et al., Optimization of the Expression of Human Aldehyde Oxidase for Investigations of Single-Nucleotide Polymorphisms. Drug Metab.Dispos. (2016)
- Release Date
- 2016-02-17
- Peptides
- Aldehyde oxidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A